These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 213948)

  • 1. Urinary phosphate and cyclic AMP in pseudohypoparathyroidism.
    Klahr S; Slatopolsky E
    Adv Exp Med Biol; 1978; 103():173-85. PubMed ID: 213948
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism.
    Sinha TK; Allen DO; Queener SF; Bell NH; Larson S; McClintock R
    J Lab Clin Med; 1977 Jun; 89(6):1188-97. PubMed ID: 194004
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone.
    Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T
    Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone and the kidney in pseudohypoparathyroidism.
    Avioli LV
    Prog Biochem Pharmacol; 1980; 17():199-203. PubMed ID: 6259657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 3'5' cyclic AMP. Diagnostic test in pseudohypoparathyroidism.
    Tze WJ; Saunders J; Drummond GI
    Arch Dis Child; 1975 Aug; 50(8):656-8. PubMed ID: 173244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parathyroid hormone-like effects of acetazolamide (author's transl)].
    Sohn H; Ikeda H; Unakami H; Hurukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1978 Aug; 54(8):949-56. PubMed ID: 214358
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG; Preiss J; Kim JK; Dousa TP
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of pseudohypoparathyroidism with frequent normocalcemia (author's transl)].
    Yumita S; Unakami H; Sohn HW; Furukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1981 Sep; 57(9):1239-46. PubMed ID: 6274713
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal.
    Drezner M; Neelon FA; Lebovitz HE
    N Engl J Med; 1973 Nov; 289(20):1056-60. PubMed ID: 4355058
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
    Breslau NA; Notman DD; Canterbury JM; Moses AM
    Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetazolamide on calcium and phosphate metabolism in type I pseudohypoparathyroidism: interaction with parathyroid hormone.
    Baran DT; Klahr S; Slatopolsky E; Avioli LV
    J Clin Endocrinol Metab; 1979 May; 48(5):766-70. PubMed ID: 219008
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R; Moses AM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary excretion of cAMP after PTH injection in patients with hypohyperparathyroidism (author's transl)].
    González Macías J; Gertner JM; Brenton DB
    Med Clin (Barc); 1979 Oct; 73(6):219-21. PubMed ID: 232737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of urinary cyclic AMP and phosphate to parathyroid extract in patients with parathyroid disorders.
    Aida M; Hurukawa Y; Miura K; Mihara A; Kato K
    Tohoku J Exp Med; 1975 Apr; 115(4):319-25. PubMed ID: 167473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone, phosphate and the kidney.
    Kleerekoper M; Bernstein RS; Rao DS; Frame B; Levin NW; Parfitt AM
    Prog Biochem Pharmacol; 1980; 17():190-8. PubMed ID: 6259656
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudohypoparathyroidism with normal serum calcium level.
    Balachandar V; Pahuja J; Maddaiah VT; Collipp PJ
    Am J Dis Child; 1975 Sep; 129(9):1092-5. PubMed ID: 171942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.
    Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C
    J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM; Tregear GW; Potts JT
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1alphaOH-vitamin D3 in a case of pseudohypoparathyroidism.
    Arita K; Tsuda T; Uezu A; Ota K; Ohata M
    Endocrinol Jpn; 1977 Apr; 24(2):207-12. PubMed ID: 194770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Clinical study of pseudohypoparathyroidism].
    Furukawa Y; Aida M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):594. PubMed ID: 4375632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.